Table 1. Rmax and EC50 for 4-cmc and caffeine activation of calcium release from control and RyR1 carrying the indicated amino acid substitutions.
Results are means±S.E.M. (n=4–19 for 4-cmc measurements or 4–15 for caffeine measurements).
Cell type | Rmax 4-cmc | EC50 4-cmc (μM) | Rmax caffeine | EC50 caffeine (mM) |
---|---|---|---|---|
WT | 0.36±0.03 | 136±33 | 0.33±0.03 | 1.08±0.33 |
Heterozygous R999H | 0.37±0.14 | 191±27 | 0.34±0.02 | 1.40±0.27 |
Homozygous P3527S | 0.23±0.04* | 75±18 | 0.43±0.04 | 1.21±0.18 |
Heterozygous P3527S | 0.34±0.04 | 157±21 | 0.40±0.03 | 1.56±0.47 |
Homozygous V4849I | 0.36±0.05 | 184±23 | 0.36±0.03 | 1.39±0.31 |
Heterozygous V4849I | 0.47±0.05 | 204±36 | 0.43±0.03 | 1.94±0.29 |
*, P<0.009 (Student's t test).